Last update 23 Jan 2025
Pharma Stulln GmbH

Pharma Stulln GmbH

Private Company|
1954|
Germany
|
< 10
|
www.pharmastulln.de

Overview

Tags

Nervous System Diseases
Other Diseases
Otorhinolaryngologic Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Endocrinology and Metabolic Disease1
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
mAChRs(Muscarinic acetylcholine receptor)1
SCNA(Sodium voltage-gated channel alpha subunits)1

Related

2
Drugs associated with Pharma Stulln GmbH
Ambroxol Hydrochloride
Target
SCNA
Mechanism
SCNA modulators
Active Org.
Shanxi Yanghe Pharmaceutical Technology Co., Ltd. [+32]
Originator Org.
Teijin Pharma Ltd.
Active Indication
Chronic sinusitis [+22]
Inactive Indication
Acute pharyngitis [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date27 May 1983
Atropine Sulfate
Target
mAChRs
Mechanism
mAChRs antagonists
Active Org.
Bausch & Lomb, Inc.Bausch & Lomb, Inc. [+37]
Originator Org.
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.
Active Indication
Myopia [+11]
Inactive Indication
Organophosphate Poisoning
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date20 Jul 1968
7
Clinical Trials associated with Pharma Stulln GmbH
EUCTR2021-004884-29-DE
/ Unknown statusPhase 2
A Randomized, Double-Blind, Placebo-Controlled Dose Finding Study of 0.05%, 0.025%, 0.01% and 0.005% Atropine Eye Drops to inhibit myopia progression in children in a European population
CTR20182052
/ CompletedPhase 1
吸入用盐酸氨溴索溶液在中国健康人群人体药代动力学研究
[Translation] Study on the pharmacokinetics of inhaled ambroxol hydrochloride solution in healthy Chinese subjects
CTR20182050
/ CompletedPhase 1
吸入用盐酸氨溴索溶液在中国健康人群人体药代动力学研究预试验
[Translation] A pilot study on the pharmacokinetics of inhaled ambroxol hydrochloride solution in healthy Chinese subjects
100 Clinical Results associated with Pharma Stulln GmbH
Login to view more data
0 Patents (Medical) associated with Pharma Stulln GmbH
Login to view more data
100 Deals associated with Pharma Stulln GmbH
Login to view more data
100 Translational Medicine associated with Pharma Stulln GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
NDA/BLA
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Atropine Sulfate
 ( mAChRs )		-
NDA/BLA
Ambroxol Hydrochloride
 ( SCNA )		Bronchopulmonary disease
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free